With what I am sure is good advice from this support group, I quit Bicaluatamide150 mg, - which I had been taking in addition to a monthly Firmagon injection - when my testosterone dropped to 9 ng/dl = 0.3 nmol/l. I understood that B gives little in addition to F when T is so low.
When I tried to contact doc about this, he let his assistant write me that I had been prescribed Bicalutamide and should continue with this for (at least) the full six-month period, simply saying that it works in a different way than Firmagon, which we all know.
I feel I need more to stand up against doc.
Anyone with advice. or study to point to? I am hesitant to go against his urging, also because I have an aggressive PC. Dx September2020, Gs 4+5, low-PSA type 1.7 at Dx, intraductal cancer in two of the biopsy samples. I had EBRT + Brachyboost late last year.
Searching past posts, I understand Bicalutamide may start feeding the cancer and, not surprisingly, have side effects. On the other hand, I saw one post pointing to a study indicating better time-to-treatment failure (TTTF) & time-to-disease progression (TTP), although not necessarily overall survival, with the combination of B and LHRH for men with advanced prostate cancer. [1] pubmed.ncbi.nlm.nih.gov/171... I can´t judge how relevant this study is for a case like mine.